Kezar Life Sciences, Inc. (KZR) Capital Expenditures (2017 - 2025)

Kezar Life Sciences (KZR) posted Capital Expenditures of $8000.0 for Q1 2025, down 27.27% sequentially from $11000.0 in Q4 2024.

Kezar Life Sciences, Inc. (KZR) Capital Expenditures (2017 - 2025) Analysis & Trends

Kezar Life Sciences has reported Capital Expenditures for 9 years, with the latest figure at $8000.0 in Q1 2025.

Quarterly Capital Expenditures changed N/A year-over-year to $8000.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $8000.0 (down 72.41% YoY) and the FY2025 annual result came in at $8000.0, down 72.41% from the prior year.
Capital Expenditures eased to $8000.0 in Q1 2025 per KZR's latest filing, from $11000.0 in the prior quarter.
Over five years, Capital Expenditures peaked at $1.5 million in Q4 2022 and troughed at -$476000.0 in Q3 2022.
A 5-year average of $297461.5 and a median of $136000.0 in 2023 frame the typical range for Capital Expenditures.
The widest YoY moves for Capital Expenditures: up 2220.83% in 2022, down 409.09% in 2022.
Over 5 years, Capital Expenditures stood at $264000.0 in 2021, then soared by 467.05% to $1.5 million in 2022, then sank by 99.93% to $1000.0 in 2023, then jumped by 1000.0% to $11000.0 in 2024, then decreased by 27.27% to $8000.0 in 2025.
According to Business Quant data, Capital Expenditures over the past three periods registered $8000.0, $11000.0, and $18000.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.

Download Data